Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The article contains sections titled: 1. General Survey 2. Adrenergic blockers, peripheral 3. Adrenergic stimulants, central 4. Angiotensin Converting Enzyme (ACE) Inhibitors 5. Angiotensin II Receptor Antagonists 6. Antiarrhythmics 6.1. Class I Antiarrhythmics 6.2. Class II Antiarrhythmics 6.3. Class III Antiarrhythmics 6.4. Class IV Antiarrhythmics 7. Anticoagulants 7.1. Synthetic Anticoagulants 7.2. Heparin and Low Molecular Weight Heparins (LMWHs) 8. Antiplatelet Drugs 9. Antilipidemic Agents (Lipid Regulating Drugs) 9.1. Bile Acid Sequestrants 9.2. Cholesterol Absorption Inhibitors 9.3. Fibrates (Fibric Acid Derivatives) 9.4. Nicotinic Acid and Derivatives 9.5. HMG‐CoA Reductase Inhibitors (Statins) 10. β‐Adrenergic Blocking Agents 11. Calcium Channel Blockers (Calcium Antagonists) 12. Diuretics 12.1. Carbonic Anhydrase Inhibitors 12.2. Loop Diuretics (High‐Ceiling Diuretics) 12.3. Potassium‐Sparing Diuretics (Antikaliuretic Agents) 12.4. Thiazides and Related Diuretics 13. Cardiac Glycosides (Positive Cardiac Inotropes) 14. Endothelin Receptor Antagonists 15. Vasodilators 15.1. Nitrates 15.2. Direct‐Acting Vasodilators 15.3. Other Vasodilators 16. Vasopressors (Sympathomimetics) References
The article contains sections titled: 1. General Survey 2. Adrenergic blockers, peripheral 3. Adrenergic stimulants, central 4. Angiotensin Converting Enzyme (ACE) Inhibitors 5. Angiotensin II Receptor Antagonists 6. Antiarrhythmics 6.1. Class I Antiarrhythmics 6.2. Class II Antiarrhythmics 6.3. Class III Antiarrhythmics 6.4. Class IV Antiarrhythmics 7. Anticoagulants 7.1. Synthetic Anticoagulants 7.2. Heparin and Low Molecular Weight Heparins (LMWHs) 8. Antiplatelet Drugs 9. Antilipidemic Agents (Lipid Regulating Drugs) 9.1. Bile Acid Sequestrants 9.2. Cholesterol Absorption Inhibitors 9.3. Fibrates (Fibric Acid Derivatives) 9.4. Nicotinic Acid and Derivatives 9.5. HMG‐CoA Reductase Inhibitors (Statins) 10. β‐Adrenergic Blocking Agents 11. Calcium Channel Blockers (Calcium Antagonists) 12. Diuretics 12.1. Carbonic Anhydrase Inhibitors 12.2. Loop Diuretics (High‐Ceiling Diuretics) 12.3. Potassium‐Sparing Diuretics (Antikaliuretic Agents) 12.4. Thiazides and Related Diuretics 13. Cardiac Glycosides (Positive Cardiac Inotropes) 14. Endothelin Receptor Antagonists 15. Vasodilators 15.1. Nitrates 15.2. Direct‐Acting Vasodilators 15.3. Other Vasodilators 16. Vasopressors (Sympathomimetics) References
The biological importance of b-lactams as antibiotics has stimulated the development of efficient procedures for the preparation of this class of compounds. Of the synthetic routes to b-lactams that have been reported, Lewis acid-promoted [1][2][3] and catalyzed [4][5][6][7][8][9][10][11] condensations of imines with silyl ketene acetals and imino-aldol condensations with ester enolates are powerful methods which involve the efficient construction of stereogenic centers of the b-lactam moiety.12-14) Chiral versions of these condensations have also been devised by the use of imines with a chiral auxiliary, [1][2][3][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] chiral ester enolate derivatives, [30][31][32][33][34][35][36] and chiral Lewis acids. [37][38][39][40][41] In the course of our studies on remote asymmetric induction using chiral sulfoxides, we previously reported the lanthanoid triflate-catalyzed Mukaiyama aldol reaction of sulfinyl aldehyde 1 with silyl ketene acetals.42) Highly remote stereocontrol of 1 in this reaction led us to examine an enantioselective route to b-lactams by diastereoselective condensation of an aldimine 2 derived from 1 with silyl ketene acetals as well as enolates. We would like to report the details of this condensation using the sulfinyl furaldimine 2. 43)Initial experiments were performed with a typical silyl ketene acetal 3a in the presence of a lanthanoid triflate, which is found to be effective for the aldol condensation of the aldehyde 1. 42) In fact, the reaction using Yb(OTf) 3 proceeded smoothly; diastereoisomeric b-amino esters 4a and 6a were produced in a ratio of 1 : 1 (Table 1, entry 1).44) The use of other lanthanoid triflates did not improve the diastereoselectivity. The relative stereochemistry of the two products 4a and 6a was not determined at this stage; however, the configuration at the C(3) position was later determined (vide infra). We then turned our attention to using an ester enolate
Among the methods of synthesizing the β‐lactam ring, the copper(I)‐mediated reaction between a nitrone and a terminal alkyne in the presence of an organic base is a remarkably simple and direct strategy. This transformation, known as the Kinugasa reaction, is a cascade process that involves a 1,3‐dipolar cycloaddition of a copper acetylide onto the nitrone, followed by a rearrangement step. Initially reported in 1972, this reaction stereoselectively allows access to cis ‐substituted β‐lactam products. Achiral, diastereoselective, and catalytic enantioselective versions of the Kinugasa reaction have been described, both in inter‐ and intramolecular contexts. To date, only aldimine‐derived nitrones have been demonstrated in the reaction. This chapter presents a comprehensive overview of the Kinugasa reaction. Mechanistic proposals and the factors involved in the stereochemistry of the reaction are followed by a discussion of the scope of the reaction and its limitations. Specifically, the combinations of aldonitrones and terminal alkynes that can be used in the achiral and diastereoselective Kinugasa reaction are presented. Enantioselective and intramolecular variants of the reaction are discussed in detail, as are successful synthetic applications, with an emphasis on the preparation of β‐lactam antibiotics. The Kinugasa reaction is compared with more classical and well‐established methods of β‐lactam synthesis, and finally, typical experimental conditions and examples of procedures for selected variants of the Kinugasa reaction are provided. The Tabular Survey covers Kinugasa reactions performed through the end of 2021.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.